A new study from the Lancet journal online reinforces earlier results that showed women may take short-duration estrogen alone without increasing their risk of breast cancer – for the average woman after menopause who has had a hysterectomy. Our own Dr. Julie Gralow comments “this finding was not true for everyone – women with a family history of breast cancer and those who have had prior biopsies, even if benign, had increased risk in this study.”
Women should always discuss the details of potential hormone use with their provider. Lead author of the study was Professor Garnet Anderson of the Fred Hutchinson Cancer Research Center, one of our founding organizations. Another feature story about the research here from Carol Ostrom at The Seattle Times.